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Abstract
© 2018,  Media  Sphera Publishing Group.  All  rights  reserved.  The review presents  current
concepts about the problem of cerebral insulin resistance (IR). It has now been established that
cerebral IR plays a key role in the pathogenesis of degenerative and metabolic diseases of the
brain. Based on literature data and own clinical experience, the authors recommend to use the
standardized extract of ginkgo biloba EGb761 as a cellular protector, which increases insulin
sensitivity of  cells  and reduces atherogenesis,  in order to improve cognitive functions and
quality of life in patients with diabetes mellitus.
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